Elizabeth C Prom-Wormley1, Jane Ebejer2, Danielle M Dick3, M Scott Bowers4. 1. Dvision of Epidemiology, Department of Family Medicine and Population Health, Virginia Commonwealth University, PO Box 980212, Richmond, VA 23298-0212, USA. Electronic address: Elizabeth.Prom-Wormley@vcuhealth.org. 2. School of Cognitive Behavioural and Social Sciences, University of New England, Armidale, NSW 2350, Australia. 3. Department of Psychology, Virginia Commonwealth University, PO Box 842509, Richmond, VA 23284-2509, USA. 4. Faulk Center for Molecular Therapeutics, Biomedical Engeneering, Northwestern University, Evanston, IL 60201, USA.
Abstract
BACKGROUND: Substance use disorder (SUD) remains a significant public health issue. A greater understanding of how genes and environment interact to regulate phenotypes comprising SUD will facilitate directed treatments and prevention. METHODS: The literature studying the neurobiological correlates of SUD with a focus on the genetic and environmental influences underlying these mechanisms was reviewed. Results from twin/family, human genetic association, gene-environment interaction, epigenetic literature, phenome-wide association studies are summarized for alcohol, nicotine, cannabinoids, cocaine, and opioids. RESULTS: There are substantial genetic influences on SUD that are expected to influence multiple neurotransmission pathways, and these influences are particularly important within the dopaminergic system. Genetic influences involved in other aspects of SUD etiology including drug processing and metabolism are also identified. Studies of gene-environment interaction emphasize the importance of environmental context in SUD. Epigenetic studies indicate drug-specific changes in gene expression as well as differences in gene expression related to the use of multiple substances. Further, gene expression is expected to differ by stage of SUD such as substance initiation versus chronic substance use. While a substantial literature has developed for alcohol and nicotine use disorders, there is comparatively less information for other commonly abused substances. CONCLUSIONS: A better understanding of genetically-mediated mechanisms involved in the neurobiology of SUD provides increased opportunity to develop behavioral and biologically based treatment and prevention of SUD.
BACKGROUND: Substance use disorder (SUD) remains a significant public health issue. A greater understanding of how genes and environment interact to regulate phenotypes comprising SUD will facilitate directed treatments and prevention. METHODS: The literature studying the neurobiological correlates of SUD with a focus on the genetic and environmental influences underlying these mechanisms was reviewed. Results from twin/family, human genetic association, gene-environment interaction, epigenetic literature, phenome-wide association studies are summarized for alcohol, nicotine, cannabinoids, cocaine, and opioids. RESULTS: There are substantial genetic influences on SUD that are expected to influence multiple neurotransmission pathways, and these influences are particularly important within the dopaminergic system. Genetic influences involved in other aspects of SUD etiology including drug processing and metabolism are also identified. Studies of gene-environment interaction emphasize the importance of environmental context in SUD. Epigenetic studies indicate drug-specific changes in gene expression as well as differences in gene expression related to the use of multiple substances. Further, gene expression is expected to differ by stage of SUD such as substance initiation versus chronic substance use. While a substantial literature has developed for alcohol and nicotine use disorders, there is comparatively less information for other commonly abused substances. CONCLUSIONS: A better understanding of genetically-mediated mechanisms involved in the neurobiology of SUD provides increased opportunity to develop behavioral and biologically based treatment and prevention of SUD.
Authors: Rohan H C Palmer; Tanya M Button; Soo H Rhee; Robin P Corley; Susan E Young; Michael C Stallings; Christian J Hopfer; John K Hewitt Journal: Drug Alcohol Depend Date: 2012-01-11 Impact factor: 4.492
Authors: Jonathan Covault; Howard Tennen; Stephen Armeli; Tamlin S Conner; Aryeh I Herman; Antonius H N Cillessen; Henry R Kranzler Journal: Biol Psychiatry Date: 2006-08-22 Impact factor: 13.382
Authors: George R Uhl; Qing-Rong Liu; Tomas Drgon; Catherine Johnson; Donna Walther; Jed E Rose; Sean P David; Ray Niaura; Caryn Lerman Journal: Arch Gen Psychiatry Date: 2008-06
Authors: Adam P Gregory; Calliope A Dendrou; Kathrine E Attfield; Aiden Haghikia; Dionysia K Xifara; Falk Butter; Gereon Poschmann; Gurman Kaur; Lydia Lambert; Oliver A Leach; Simone Prömel; Divya Punwani; James H Felce; Simon J Davis; Ralf Gold; Finn C Nielsen; Richard M Siegel; Matthias Mann; John I Bell; Gil McVean; Lars Fugger Journal: Nature Date: 2012-08-23 Impact factor: 49.962
Authors: Valentina Ivezaj; Stephen C Benoit; Jon Davis; Scott Engel; Celia Lloret-Linares; James E Mitchell; M Yanina Pepino; Ann M Rogers; Kristine Steffen; Stephanie Sogg Journal: Curr Psychiatry Rep Date: 2019-08-13 Impact factor: 5.285
Authors: Kristine Marceau; Leslie A Brick; Joëlle A Pasman; Valerie S Knopik; Sijmen A Reijneveld Journal: Eur Addict Res Date: 2021-11-30 Impact factor: 4.000
Authors: Jing Zhu; Ryan J Beechinor; Trey Thompson; Allison N Schorzman; William Zamboni; Daniel J Crona; Daniel L Weiner; Lisa M Tarantino Journal: Genes Brain Behav Date: 2020-05-29 Impact factor: 3.449